SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Palmer Colin)
 

Search: WFRF:(Palmer Colin) > A common missense v...

A common missense variant of LILRB5 is associated with statin intolerance and myalgia

Siddiqui, Moneeza K. (author)
Maroteau, Cyrielle (author)
Veluchamy, Abirami (author)
show more...
Tornio, Aleksi (author)
Tavendale, Roger (author)
Carr, Fiona (author)
Abelega, Ngu-Uma (author)
Carr, Dan (author)
Bloch, Katyrzyna (author)
Hallberg, Pär 1974- (author)
Yue, Qun-Ying (author)
Pearson, Ewan R. (author)
Colhoun, Helen M. (author)
Morris, Andrew D. (author)
Dow, Eleanor (author)
George, Jacob (author)
Pirmohamed, Munir (author)
Ridker, Paul M. (author)
Doney, Alex S. F. (author)
Alfirevic, Ana (author)
Wadelius, Mia (author)
Maitland-van der Zee, Anke-Hilse (author)
Chasman, Daniel I. (author)
Palmer, Colin N. A. (author)
show less...
 (publisher)
2017
2017
English.
In: European Heart Journal. - 0195-668X. ; 38:48, 3569-U31
  • swepub:Mat__t
Abstract Subject headings
Close  
  • Aims: A genetic variant in LILRB5 (leukocyte immunoglobulin-like receptor subfamily-B) (rs12975366: T > C: Asp247Gly) has been reported to be associated with lower creatine phosphokinase (CK) and lactate dehydrogenase (LDH) levels. Both biomarkers are released from injured muscle tissue, making this variant a potential candidate for susceptibility to muscle-related symptoms. We examined the association of this variant with statin intolerance ascertained from electronic medical records in the GoDARTS study. Methods and results: In the GoDARTS cohort, the LILRB5 Asp247 variant was associated with statin intolerance (SI) phenotypes; one defined as having raised CK and being non-adherent to therapy [odds ratio (OR) 1.81; 95% confidence interval (CI): 1.34–2.45] and the other as being intolerant to the lowest approved dose of a statin before being switched to two or more other statins (OR 1.36; 95% CI: 1.07–1.73). Those homozygous for Asp247 had increased odds of developing both definitions of intolerance. Importantly the second definition did not rely on CK elevations. These results were replicated in adjudicated cases of statin-induced myopathy in the PREDICTION-ADR consortium (OR1.48; 95% CI: 1.05–2.10) and for the development of myalgia in the JUPITER randomized clinical trial of rosuvastatin (OR1.35, 95% CI: 1.10–1.68). A meta-analysis across the studies showed a consistent association between Asp247Gly and outcomes associated with SI (OR1.34; 95% CI: 1.16–1.54). Conclusion: This study presents a novel immunogenetic factor associated with statin intolerance, an important risk factor for cardiovascular outcomes. The results suggest that true statin-induced myalgia and non-specific myalgia are distinct, with a potential role for the immune system in their development. We identify a genetic group that is more likely to be intolerant to their statins.

Subject headings

Medical and Health Sciences  (hsv)
Clinical Medicine  (hsv)
Cardiac and Cardiovascular Systems  (hsv)
Medicin och hälsovetenskap  (hsv)
Klinisk medicin  (hsv)
Kardiologi  (hsv)

Keyword

Statins
Pharmacogenetics
Immunogenetics
Precision medicine
Adverse drug reactions
Myalgia

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view